Equities Research Analysts’ new coverage for Thursday, September 14th:

Royal Bank Of Canada assumed coverage on shares of Alder BioPharmaceuticals (NASDAQ:ALDR). The firm issued an outperform rating on the stock.

Nomura assumed coverage on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY). Nomura issued a reduce rating and a $56.00 target price on the stock.

Royal Bank Of Canada initiated coverage on shares of AnaptysBio (NASDAQ:ANAB). The firm issued an outperform rating on the stock.

Royal Bank Of Canada assumed coverage on shares of AveXis (NASDAQ:AVXS). The firm issued a sector perform rating on the stock.

Royal Bank Of Canada assumed coverage on shares of BioCryst Pharmaceuticals (NASDAQ:BCRX). Royal Bank Of Canada issued a sector perform rating on the stock.

Royal Bank Of Canada initiated coverage on shares of Biogen (NASDAQ:BIIB). Royal Bank Of Canada issued a sector perform rating on the stock.

Royal Bank Of Canada began coverage on shares of Bioverativ (NASDAQ:BIVV). They issued a sector perform rating on the stock.

Royal Bank Of Canada assumed coverage on shares of BioMarin Pharmaceutical (NASDAQ:BMRN). They issued a sector perform rating on the stock.

Macquarie initiated coverage on shares of Coca-Cola European Partners plc (NYSE:CCE). Macquarie issued an outperform rating on the stock.

Royal Bank Of Canada initiated coverage on shares of Celgene Corporation (NASDAQ:CELG). They issued a top pick rating on the stock.

Macquarie began coverage on shares of Colgate-Palmolive (NYSE:CL). They issued a neutral rating on the stock.

Royal Bank Of Canada initiated coverage on shares of Enanta Pharmaceuticals (NASDAQ:ENTA). The firm issued an outperform rating on the stock.

Royal Bank Of Canada began coverage on shares of Five Prime Therapeutics (NASDAQ:FPRX). The firm issued an outperform rating on the stock.

Robert W. Baird assumed coverage on shares of H. B. Fuller (NYSE:FUL). Robert W. Baird issued a neutral rating on the stock.

Royal Bank Of Canada initiated coverage on shares of Galapagos NV (NASDAQ:GLPG). The firm issued a sector perform rating on the stock.

Royal Bank Of Canada initiated coverage on shares of Intercept Pharmaceuticals (NASDAQ:ICPT). They issued an outperform rating on the stock.

Royal Bank Of Canada assumed coverage on shares of Immune Design Corp. (NASDAQ:IMDZ). They issued an outperform rating on the stock.

Macquarie assumed coverage on shares of Monster Beverage Corporation (NASDAQ:MNST). Macquarie issued an outperform rating on the stock.

Royal Bank Of Canada initiated coverage on shares of ObsEva SA (NASDAQ:OBSV). The firm issued an outperform rating on the stock.

Raymond James Financial, Inc. initiated coverage on shares of Oclaro (NASDAQ:OCLR). They issued a strong-buy rating and a $12.00 target price on the stock.

Macquarie initiated coverage on shares of Pepsico (NYSE:PEP). The firm issued an outperform rating on the stock.

Macquarie began coverage on shares of Procter & Gamble Company (The) (NYSE:PG). They issued an outperform rating on the stock.

Royal Bank Of Canada assumed coverage on shares of Prothena Corporation PLC (NASDAQ:PRTA). The firm issued an outperform rating on the stock.

SunTrust Banks, Inc. initiated coverage on shares of Red Rock Resorts (NASDAQ:RRR). SunTrust Banks, Inc. issued a buy rating on the stock.

Royal Bank Of Canada assumed coverage on shares of Sage Therapeutics (NASDAQ:SAGE). The firm issued an outperform rating on the stock.

Macquarie started coverage on shares of Boston Beer Company, Inc. (The) (NYSE:SAM). Macquarie issued an underperform rating on the stock.

DA Davidson began coverage on shares of SS&C Technologies Holdings (NASDAQ:SSNC). They issued a buy rating on the stock.

Macquarie initiated coverage on shares of Constellation Brands (NYSE:STZ). Macquarie issued an outperform rating on the stock.

Royal Bank Of Canada started coverage on shares of Acceleron Pharma (NASDAQ:XLRN). Royal Bank Of Canada issued a sector perform rating on the stock.

Receive News & Ratings for Alder BioPharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alder BioPharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.